Hasan R, Rink L, Haase H
Gastroenterology 2020;159:1290-301.e5.ArticlePubMed 877
Some of the more common side effects in clinical trials compared to placebo include: Gastrointestinal side effects such as nausea, vomiting, constipation, or diarrhea Abdominal pain Headache, dizziness Fatigue Dyspepsia, abdominal distension, eructation Hypoglycemia (low blood sugar) in patients with type 2 diabetes Flatulence, gastroenteritis, and gastroesophageal reflux disease (heartburn) Hypoglycemia (low blood sugar levels), a more serious side effect of GLP-1 drugs, may also occur
What the Research Shows: BPC-157 and Knee Structures All BPC-157 research on knee-specific structures comes from animal models, with one exception
Both offer unique benefits for skin whitening and overall health
GLP-1 / GIP Program Pricing GLP-1 and GIP-based programs (semaglutide or tirzepatide) are available through licensed U.S